Ropinirole ruled out by EXPERTS-ALS drug-screening platform
A second interim analysis from EXPERTS-ALS finds that ropinirole did [...]
Apathy in MND may reflect how much harder daily tasks have become, not a loss of motivation
A University of Sheffield study, supported by people who took [...]
New study identifies a genetic cause of MND in one in four people with the condition
A major international study has found that one in four [...]
New drug smilagenin to be evaluated through EXPERTS-ALS platform
A new candidate treatment for motor neuron disease (MND) will [...]
UK MND RI biomarkers research programme reaches recruitment target
The UK MND RI’s biosampling platform has now recruited 212 [...]
Could biomarkers transform ALS clinical trials and accelerate treatment development?
A new systematic review highlights how biomarkers, biological indicators of [...]
Traumatic brain injury linked to higher short-term risk of MND, UK-wide study finds
A new UK-wide study has found that people who experience [...]
Fatigue in MND: New study reveals its prevalence, impact and trajectories
A new UK-wide study has found that fatigue is one [...]
Raya Therapeutic joins EXPERTS-ALS to accelerate ALS/MND treatment development
Raya Therapeutic Inc. has announced that one of its five [...]
Blood-based protein test could predict ALS up to a decade before symptoms appear
A new study has identified a blood-based biomarker panel capable [...]
